Animal Drugs, Feeds, and Related Products; Febantel-Trichlorfon Paste and Tylosin

Riepilogo

The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions of the regulations that reflect approval of two new animal drug applications (NADA's). One NADA is held by Miles, Inc., and provides for use of febantel-trichlorfon paste. The other NADA is held by Nutra-Blend Corp. and provides for manufacture of a Type A medicated article and Type B medicated feeds containing tylosin. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of the NADA's.